Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | Prathmesh DistributorLikely | Evaluation in Progress | 6 | ₹34,560 |
| 2 | Schedule 2 | SMPL LIFE SCIENCES PRIVATE LIMITEDLikely | Evaluation in Progress | 1 | ₹1.8 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
27 Jan 2024, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Trimetazidine hcl sr 35mg Tab (Q3)
Hyaluronic acid 6ml Inj (Intra articular) (Q3)
5798533
GEM/2023/B/4394279
Two Packet Bid
Trimetazidine hcl sr 35mg Tab,Hyaluronic acid 6ml Inj (Intra articular)
15 days
Delhi; New Delhi
Item wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
₹31
50%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Trimetazidine hcl sr 35mg Tab (Q3) | NEW DELHI | 43,200 | 15 days | - |
| Hyaluronic acid 6ml Inj (Intra articular) (Q3) | NEW DELHI | 43 | 15 days |
Exempted
27 Jan 2024
26 Dec 2023
27 Jan 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5798533.pdf
GEM_BID
cfare66_2023-12-26-12-17-10_61379597dfd47310804308e68d58c322.pdf
SPECIFICATION
cfare66_2023-12-26-12-19-11_69cb6bc7920f2edf44efc9128633f47c.pdf
SPECIFICATION
CFARE66_cadbd51d-acd2-469f-803a1703573935469_sauravroy.148l@gov.in.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .